Tyler J Alban

11PUBLICATIONS
123CO-AUTHORS
Infant and child healthSemi- and unsupervised learningMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Developmental genetics (incl. sex determination)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 30, 2026
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG.

|Jun 04, 2026
Quantum ensembling methods for healthcare and life science.

|May 08, 2026
Novel Mechanism of and Therapeutic Approach for Anthracycline-Induced Cardiotoxicity.

|Feb 05, 2026
The Impact of Immunotherapy on Incidence of Second Primary Malignancies: A Surrogate for Antitumor Surveillance Activation.

Bridget Adcock, Moaath K Mustafa Ali, Emily C Zabor

|Jan 02, 2026
Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer.

Nadeem Riaz, Tyler J Alban, Robert I Haddad

|Jan 02, 2026
Intratumoral bacteria are immunosuppressive and promote immunotherapy resistance in head and neck squamous cell carcinoma.

Natalie L Silver, Jin Dai, Travis D Kerr

Pageof 2

Frequent Collaborators

9 joint publications

Timothy Chan

7 joint publications

Prerana Parthasarathy

5 joint publications

Vladimir Makarov

3 joint publications

Paul Pavicic